Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta globin gene inhibition by antisense RNA transcripts.

L Xu1, A E Ferry, C Monteiro

  • 1Department of Biology, University of South Alabama, Mobile, AL 36688, USA.

Gene Therapy
|March 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dhvar5- and MSI78-coated titanium are bactericidal against methicillin-resistant Staphylococcus aureus, immunomodulatory and osteogenic.

Acta biomaterialia·2024
Same author

Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies.

The journal of prevention of Alzheimer's disease·2024
Same author

Dhvar5-chitosan nanogels and their potential to improve antibiotics activity.

International journal of biological macromolecules·2024
Same author

Neurocognitive and psychological comorbidities in patients with self-limited centrotemporal spike epilepsy. A case-control study.

Revista de neurologia·2023
Same author

Complete pathological response (pCR) in gastroesophageal cancer: Correlation with metabolic response.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2020
Same author

Semen quality is affected by HLA class I alleles together with sexually transmitted diseases.

Andrology·2019
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Antisense cDNA expression vectors can inhibit beta globin gene expression, offering a potential gene therapy for sickle cell disease (SCD). This approach reduced beta chains and increased gamma chains in erythroid cells.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Hematology

Background:

  • Sickle cell disease (SCD) stems from a beta globin gene mutation, causing abnormal hemoglobin S (Hb S) and red blood cell dysfunction.
  • Preventing Hb S polymerization is key to treating SCD symptoms.
  • Antisense technology offers a potential strategy for modulating gene expression.

Purpose of the Study:

  • To evaluate the efficacy of a mammalian expression vector with human beta globin antisense cDNA (pZeobetaAS) in inhibiting beta globin gene expression.
  • To assess the impact of pZeobetaAS on both cell lines and primary erythroid progenitors.
  • To explore antisense cDNA as a novel gene therapy for sickle cell disease.

Main Methods:

  • Transfection of a mouse erythroleukemia cell line with pZeobetaAS.

Related Experiment Videos

  • Analysis of beta and gamma globin mRNA levels using quantitative methods.
  • Assessment of globin chain biosynthesis at the protein level.
  • Transfection of primary erythroid progenitors to study effects during differentiation.

    • Main Results:

    • The pZeobetaAS vector significantly reduced beta globin mRNA levels relative to gamma mRNA.
    • Protein analysis revealed a 76% decrease in beta chain production and a 517% increase in gamma chain biosynthesis.
    • The inhibitory effect on globin expression was sustained long-term in cell cultures.
    • Similar reductions in beta globin mRNA were observed in primary erythroid progenitors.

    Conclusions:

    • Antisense cDNA expression vectors, like pZeobetaAS, demonstrate a novel therapeutic potential.
    • This approach effectively inhibits beta globin gene expression in erythroid cells.
    • Antisense technology represents a promising gene therapy strategy for sickle cell disease.